Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1330
-0.0050 (-3.62%)
May 21, 2026, 11:21 AM CET
Spago Nanomedical AB Revenue
Spago Nanomedical AB had revenue of 1.07M SEK in the quarter ending March 31, 2026, a decrease of -29.05%. This brings the company's revenue in the last twelve months to 4.38M, down -34.90% year-over-year. In the year 2025, Spago Nanomedical AB had annual revenue of 4.82M, down -27.53%.
Revenue (ttm)
4.38M
Revenue Growth
-34.90%
P/S Ratio
20.83
Revenue / Employee
626.29K
Employees
7
Market Cap
91.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.82M | -1.83M | -27.53% |
| Dec 31, 2024 | 6.65M | 1.01M | 17.94% |
| Dec 31, 2023 | 5.64M | -562.00K | -9.06% |
| Dec 31, 2022 | 6.20M | -279.00K | -4.30% |
| Dec 31, 2021 | 6.48M | -679.00K | -9.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Magle Chemoswed Holding AB | 287.55M |
| IRLAB Therapeutics AB | 92.46M |
| Alzinova AB | 25.66M |
| Scandinavian ChemoTech AB | 12.61M |
| Biovica International AB | 10.93M |
| AcouSort AB | 10.43M |
| NextCell Pharma AB | 9.83M |
| OncoZenge AB | 2.78M |
Spago Nanomedical AB News
- 6 months ago - Spago Nanomedical AB Transcript: Life Science Summit 2025 - Transcripts